Digestive department
Service
Hospital de Galdakao - Usansolo
Galdácano, EspañaPublications in collaboration with researchers from Hospital de Galdakao - Usansolo (52)
2024
-
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial
The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 802-810
-
Baiona's Consensus Statement for Fecal Incontinence. Spanish Association of Coloproctology
Cirugia Espanola, Vol. 102, Núm. 3, pp. 158-173
-
Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial
Digestive Diseases
-
Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study
Journal of Clinical Medicine, Vol. 13, Núm. 2
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
2022
-
Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study
Alimentary pharmacology & therapeutics, Vol. 55, Núm. 11, pp. 1402-1413
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project
Gastroenterologia y Hepatologia, Vol. 45, Núm. 10, pp. 737-741
-
The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study
Journal of Crohn's & colitis, Vol. 16, Núm. 11, pp. 1676-1686
-
The diagnose and leave in strategy for diminutive rectosigmoid polyps in Lynch syndrome: A post hoc analysis from a randomized controlled trial
Endoscopy, Vol. 54, Núm. 1, pp. 27-34
2021
-
Corrigendum to “Recomendaciones del Grupo Español de Trabajo en enfermedad de Crohn y colitis ulcerosa (GETECCU) sobre la reservoritis en la colitis ulcerosa. Parte 2: Tratamiento” [Gastroenterología y Hepatología 2020;43(10):649-658](S0210570520301606)(10.1016/j.gastrohep.2020.04.004)
Gastroenterologia y Hepatologia
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
-
Increased use of healthcare resources during the preclinical period of inflammatory bowel disease
Digestive and Liver Disease
-
Look at Both Sides of the Coin in Determining Risk of Complicated Crohn's Disease
Clinical Gastroenterology and Hepatology
-
Risk of Depression during the Natural History of Inflammatory Bowel Disease: The Phantom Menace
Inflammatory Bowel Diseases
-
Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies
Gastroenterologia y Hepatologia, Vol. 44, Núm. 8, pp. 587-598
2020
-
COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)
Gastroenterologia y Hepatologia, Vol. 43, Núm. 7, pp. 408-413
-
Clinical validation of risk scoring systems to predict risk of delayed bleeding after EMR of large colorectal lesions
Gastrointestinal Endoscopy, Vol. 91, Núm. 4, pp. 868-878.e3
-
Early microscopic findings in preclinical inflammatory bowel disease
Digestive and Liver Disease, Vol. 52, Núm. 12, pp. 1467-1472
-
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066